NSTEMI Diagnostic Criteria
NSTEMI is diagnosed when a patient presents with evidence of myocardial necrosis (elevated cardiac troponin with rise and/or fall pattern) in the setting of acute myocardial ischemia, but WITHOUT ST-segment elevation on ECG that meets STEMI criteria. 1
Core Diagnostic Requirements
To diagnose NSTEMI, you must have all of the following:
1. Elevated Cardiac Biomarkers
- Cardiac troponin (cTn) above the 99th percentile upper reference limit (URL) with a rising and/or falling pattern 1
- If troponin unavailable, CK-MB mass assay above 99th percentile URL is acceptable (though inferior) 1
- Use sex-specific values when available 1
2. Clinical Evidence of Myocardial Ischemia (at least ONE of):
- Symptoms of ischemia (chest discomfort, upper extremity/mandibular/epigastric pain, dyspnea, fatigue, diaphoresis) typically lasting >20 minutes 1
- New or presumed new significant ST-segment–T wave changes (but NOT meeting STEMI criteria) 1
- Development of pathological Q waves 1
- Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality 1
- Identification of intracoronary thrombus by angiography 1
3. Absence of ST-Elevation
- The ECG must NOT show ST-segment elevation meeting guideline criteria for STEMI 1
- This is the key distinguishing feature from STEMI
Critical Diagnostic Nuances
The troponin elevation must demonstrate a dynamic pattern (rise and/or fall), not just a single elevated value. Static elevation without clinical ischemia suggests alternative diagnoses like myocarditis, pulmonary embolism, heart failure, or chronic kidney disease 1.
Timing matters for serial troponin testing: At least one sample at presentation and a second sample at least 6 hours later to identify the dynamic pattern 2. High-sensitivity troponin assays now enable rapid 0/1-hour or 0/2-hour algorithms 3.
Common Pitfalls to Avoid
Do not diagnose NSTEMI based solely on elevated troponin. Approximately 49% of patients with elevated troponins in the ED have non-ACS causes 4. The diagnosis requires the clinical context of ischemia.
Beware of the "normal ECG" trap: 1-8% of confirmed NSTEMI patients present with completely normal initial ECGs 3. These patients often have single-vessel disease, non-obstructive CAD, or coronary vasospasm. Serial ECGs and high-sensitivity troponin testing are essential.
NSTEMI does not equal "non-occlusive": A significant proportion of NSTEMI patients have acute total coronary occlusion on angiography 5, 6. The ECG classification (STEMI vs NSTEMI) is imperfect for identifying which patients have complete vessel occlusion requiring emergent intervention.
Risk Factors Associated with True ACS
When troponin is elevated, these features increase likelihood of true NSTEMI 4:
- Presence of chest pain (OR 3.7)
- Tobacco smoking (OR 4.0)
- Wall motion abnormalities on echocardiogram (OR 3.8)
Procedural and Device-Related NSTEMI
PCI-related MI: Troponin elevation >5× the 99th percentile URL in patients with normal baseline (or >20% rise if baseline already elevated) PLUS symptoms, new ECG changes, angiographic complications, or imaging evidence of new myocardial loss 1.
Stent thrombosis: Detected by angiography or autopsy with ischemic symptoms and troponin rise/fall above 99th percentile 1.